Follow on Google News News By Tag Industry News Country(s) Industry News
Follow on Google News | Global market for biosimilars predicted to reach $2.45bln in 2013SMi's Biosimilars: Commercial Strategies and Regulatory Guidelines masterclass, taking place on the 9 December in London, will address the common pitfalls in and around biosimilar regulatory requirements in both Europe and the US.
By: smi group (Source: Thomson Reuters, What to make of the Biosimilars Market?, 2013) SMi's masterclass hosted by Interpharm Consultancy, will address the common pitfalls in and around biosimilar regulatory requirements in both Europe and the US. Case study led and extremely informative, Peter Wittner looks to help identify both successful and unsuccessful applications in regards to biosimilar regulatory approval in a bid to better inform attendees of how they might approach different markets. --Ends-- Masterclass Host Peter Wittner, Senior Consultant, Interpharm Consultancy Peter Wittner, B.Sc., is an independent consultant specialising in the commercial aspects of generics with more than 30 years’ pharmaceutical experience. Before starting his own business, Peter headed the European sales and marketing departments of the UK generics companies Evans Medical and H.N, Norton, Which later became part of IVAX. For more information please visit: http://www.smi- Alternatively please contact: Fateja Begum, fbegum@smi-online.co.uk (mailto:agibbons@ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|